Investor Summit is the largest independent investor conference on the East Coast. This independence allows a sharp focus on customer service and scheduling high-quality meetings between the attending executives and investors. Investor Summit sets the bar for quality service in a space traditionally dominated by banks who focus more on selling their services than on building the connections your company needs to succeed. Conference organizers have facilitated countless valuable interactions for the event's presenting companies, which have often led to increased exposure, market value appreciation, and long-term growth. For more information visit microcapconf.com
- A
- ACCO Brands Corp.
- Annovis Bio Inc.
- Arch Therapeutics Inc.
- Arcimoto Inc.
- Artelo Biosciences Inc.
- Atlas 365 Inc.
- AzurRx BioPharma Inc.
- B
- Bach Pharma
- Black Iron Inc.
- Bluerock Residential Growth REIT Inc.
- C
- Charles & Colvard Ltd.
- Citius Pharmaceuticals Inc.
- Comstock Mining Inc.
- Crawford United Corp.
- D
- Dyadic International Inc.
- E
- ExOne Company
ACCO Brands Corp. (NYSE: ACCO)
ACCO Brands (NYSE: ACCO) is one of the world's largest designers, marketers and manufacturers of branded academic, consumer and business products. The company's widely recognized brands include Artline®, AT-A-GLANCE®, Barrilito®, Derwent®, Esselte®, Five Star®, Foroni, GBC®, Hilroy®, Kensington®, Leitz®, Mead®, Quartet®, Rapid®, Rexel®, Swingline®, Tilibra®, Wilson Jones® and many others. ACCO Brands' products are sold in more than 100 countries around the world. For more information, visit the company's website at www.accobrands.com
Annovis Bio Inc. (NYSE: ANVS)
Annovis Bio (NYSE: ANVS) is a clinical-stage drug platform company addressing neurodegeneration, such as Alzheimer's disease (AD), Parkinson's disease (PD) and Alzheimer's in Down syndrome (AD-DS). Annovis believes it is the only company developing a drug for AD, PD and AD-DS that inhibits more than one neurotoxic protein and, thereby, improves the information highway of the nerve cell, known as axonal transport. When this information flow is impaired, the nerve cell gets sick and dies. The company expects its treatment to improve memory loss and dementia associated with AD and AD-DS as well as body and brain function in PD. Annovis has an ongoing phase 2a study in AD patients and plans to commence a second phase 2a study in PD patients. For more information, visit the company's website at www.annovisbio.com
Arch Therapeutics Inc. (OTCQB: ARTH)
Arch Therapeutics (OTCQB: ARTH) is developing innovative self-assembling barrier technologies to improve wound care outcomes, enhance the quality of patient care by health care personnel, and offer compelling options to health care institutions facing limited resources. For more information, visit the company's website at www.archtherapeutics.com
Arcimoto Inc. (NASDAQ: FUV)
Arcimoto (NASDAQ: FUV) is devising new technologies and patterns of mobility that raise the bar for environmental efficiency, footprint and affordability. Available for preorder today, Arcimoto's Fun Utility Vehicle, Rapid Responder and Deliverator are some of the lightest, most affordable and most appropriate electric vehicles suitable for everyday transport. Acrimoto is headquartered in Eugene, Oregon. For more information, visit the company's website at www.arcimoto.com
Artelo Biosciences Inc. (NASDAQ: ARTL)
Artelo Biosciences (NASDAQ: ARTL) is a biopharmaceutical company dedicated to the development and commercialization of proprietary therapeutics targeting the endocannabinoid system. Artelo is rapidly advancing a portfolio of broadly applicable product candidates designed to address significant unmet needs in multiple diseases and conditions, including anorexia, cancer, pain and inflammation. Led by proven biopharmaceutical executives collaborating with highly respected researchers and technology experts, the company applies leading-edge scientific, regulatory and commercial discipline to develop high-impact therapies. For more information, visit the company's website at www.artelobio.com
Atlas 365 Inc.
Atlas 365 is a Toronto-based company with the mission of enhancing climate resilience with industrial hemp and technology. The company's organization is diversified and vertically integrated to undertake activities in agriculture; biomaterials product development; and housing while leveraging leading-edge technology. The primary focus supporting the industrial hemp value chain in order to make an impact on global sustainability as measured by the UN Sustainable Development Goals (SDG). For more information, visit the company's website at www.atlas365.ca
AzurRx BioPharma Inc. (NASDAQ: AZRX)
AzurRx BioPharma (NASDAQ: AZRX) is a development-stage biopharmaceutical company focused on the development of recombinant proteins for the treatment of gastrointestinal diseases and microbiome-related conditions. For more information, visit the company's website at www.azurrx.com
Bach Pharma
Bach Pharma, is an advanced clinical-stage drug development company with a therapeutic platform technology based on monosodium luminol that addresses multi-billion-dollar markets for the treatment of neuroimmunodegenerative (NID) diseases such as ALS ("Lou Gehrig's Disease"), Alzheimer's, Parkinson's, multiple sclerosis, and Gulf War Illness (GWI). Bach's drugs have an excellent safety and efficacy profile. For more information, visit the company's website at www.bachpharma.com
Black Iron Inc. (TSX: BKI) (OTCQB: BKIRF)
Black Iron (TSX: BKI) (OTC: BKIRF) is developing an iron ore mine ranked as the lowest-cost undeveloped project globally by both CRU and Wood MacKenzie. Black Iron differentiates itself with exceptional infrastructure access, along with the very high 68% iron content purity of its final product. The company's project is located in an established mining region surrounded by five operating iron ore mines owned by leading companies, including ArcelorMittal, Metinvest and Evraz. Black Iron's cost to mine, process, rail and load a ship is estimated at only US$33/T for an ultrahigh grade 68% iron content product (top 4% globally = lower GHG emissions to produce steel). Using a long-term iron-ore price of US$62/T (current actual ~$90/T) results in a 34% IRR and US$1.4billion NPV (10% discount rate) after tax for a company with current market capitalization of only ~US$9 million (~CND$12 million). For more information, visit the company's website at www.blackiron.com
Bluerock Residential Growth REIT Inc. (NYSE: BRG)
Bluerock Residential Growth (NYSE: BRG) is a REIT that focuses on acquiring a diversified portfolio of class A institutional-quality apartment properties in demographically attractive growth markets to appeal to the renter by choice. The company's objective is to generate value through off-market/relationship-based transactions and, at the asset level, through improvements to operations and properties. The company generally invests with strategic regional partners, including some of the best-regarded private owner-operators in the United States, making it possible to operate as a local sharpshooter in each of its markets while enhancing off-market sourcing capabilities. For more information, visit the company's website at www.bluerockresidential.com
Charles & Colvard Ltd. (NASDAQ: CTHR)
Charles & Colvard (NASDAQ: CTHR) believes luxury can be beautiful and conscientious. As an e-commerce-driven business, the company brings revolutionary gemstones and jewelry to market through the use of innovative technology and direct-to-consumer engagement. Charles & Colvard is the original pioneer of lab-created moissanite, a rare gemstone formed from silicon carbide. Consumers seek Charles & Colvard fashion, bridal and fine jewelry because of its exceptional quality, incredible value and shared beliefs in environmental and social responsibility. Charles & Colvard was founded in 1995 and is based in North Carolina's Research Triangle. For more information, visit the company's website at www.charlesandcolvard.com
Citius Pharmaceuticals Inc. (NASDAQ: CTXR)
Citius Pharmaceuticals (NASDAQ: CTXR) is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products, with a focus on anti-infectives, cancer care and unique prescription products that use innovative, patented or proprietary formulations of previously approved active pharmaceutical ingredients. The company seeks to achieve leading market positions by providing therapeutic products that address unmet medical needs. By using previously approved drugs with substantial safety and efficacy data, Citius seeks to reduce the risks associated with pharmaceutical product development and regulatory requirements. Citius develops products that have intellectual property protection and competitive advantages to existing therapeutic approaches. For more information, visit the company's website at www.citiuspharma.com
Comstock Mining Inc. (NYSE: LODE)
Comstock Mining (NYSE: LODE) is a Nevada-based gold and silver mining company with extensive, contiguous property in the Comstock District and is an emerging leader in sustainable, responsible mining. The company is currently commercializing environment-enhancing, precious metal-based technologies, products and processes for precious metal recovery. The company began acquiring properties in the Comstock District in 2003. Since then, the company has consolidated a significant portion of the Comstock District, amassed the single largest known repository of historical and current geological data on the Comstock region, secured permits, built an infrastructure and completed its first phase of production. The company continues evaluating and acquiring properties inside and outside the district, expanding its footprint and exploring all of its existing and prospective opportunities for further exploration, development and mining. For more information, visit the company's website at www.comstockmining.com
Crawford United Corp. (OTC: CRAWA)
Crawford United (OTC: CRAWA) is a growth-oriented holding company providing specialty industrial products to diverse markets, including healthcare, aerospace, education, transportation and petrochemical. For more information, visit the company's website at www.crawfordunited.com
Dyadic International Inc. (NASDAQ: DYAI)
Dyadic International (NASDAQ: DYAI) is a global biotechnology company focused on improving and applying its proprietary C1 gene expression platform, based on a patented and proprietary genetically modified strain of the fungus Myceliophthora thermophila, to address opportunities in the human and animal health markets. C1 is a potentially game-changing biopharmaceutical gene expression platform that may help bring biologic vaccines, drugs and other biologic products to market faster than existing expression platforms, such as Chinese hamster ovary (CHO) cells, E. coli and others, in greater volumes, at lower cost and with new properties that can improve access and cost to patients and the healthcare system. For more information, visit the company's website at www.dyadic.com
ExOne Company (NASDAQ: XONE)
ExOne (NASDAQ: XONE) is a global provider of 3D printing machines and 3D printed and other products, materials and services to industrial customers. ExOne's business primarily consists of manufacturing and selling 3D printing machines and printing products to specification for its customers using its installed base of 3D printing machines. For more information, visit the company's website at www.exone.com
Generation Hemp Inc. (OTC: GENH)
Generation Hemp (OTC: GENH) is a pure play hemp company with operations in Denver, Colorado, and Dallas, Texas. Headed up by Gary C. Evans, a serial entrepreneur who has raised $4.5 billion in the capital markets throughout his career, Gen Hemp seeks to become a leading seed-to-sale hemp company by deploying an aggressive and strategic roll-up strategy. For more information, visit the company's website at www.genhempinc.com
Graham Corp. (NYSE: GHM)
Graham (NYSE: GHM) is a global business that designs, manufactures and sells critical equipment for the energy, defense and chemical/petrochemical industries. Energy markets include oil refining, cogeneration and alternative power. For the defense industry, the company's equipment is used in nuclear propulsion power systems for the U.S. Navy. Graham's global brand is built upon world-renowned engineering expertise in vacuum and heat transfer technology, responsive and flexible service, and unsurpassed quality. Graham designs and manufactures custom-engineered ejectors, vacuum pumping systems, surface condensers and vacuum systems. Graham's equipment can also be found in other diverse applications such as metal refining, pulp and paper processing, water heating, refrigeration, desalination, food processing, pharmaceutical, heating, ventilating and air conditioning. For more information, visit the company's website at www.graham-mfg.com
Heidrick & Struggles (NASDAQ: HSII)
Heidrick & Struggles (NASDAQ: HSII) assists the world's top organizations with their senior-level talent and leadership needs. Specializing in executive search, leadership assessment and development, organization and team effectiveness, and culture shaping services, the company pioneered the profession of executive search nearly seven decades ago. Today, Heidrick & Struggles Operates from principal business centers in North America, Latin America, Europe, the Middle East, Africa and Asia Pacific. For more information, visit the company's website at www.heidrick.com
International Seaways Inc. (NYSE: INSW)
International Seaways (NYSE: INSW) owns and operates a fleet of 41 vessels including 39 conventional tankers. Through joint-venture partnerships, the company has ownership interests in two floating storage vessels. International Seaways provides shipping services to customers through voyage charters, commercial pools and time charters. International Seaways believes that its seafarers are as crucial to its success as the team ashore that supports them. Through its technical and commercial management partners and its own in-house expertise, International Seaways has the global network in place to support its seafarers and deliver shipping services safely and effectively to its customers. For more information, visit the company's website at www.intlseas.com
Kontrol Energy Corp. (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8)
Kontrol Energy Corp. (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8) helps its customers reduce their overall cost of energy and greenhouse gas (GHG) emissions through IoT, cloud, blockchain and SaaS technologies. With their core focus on creating a sustainable future for all, management of the company believes the energy efficiency sector is ripe for consolidation and is focused on acquiring majority positions in small private companies which are profitable and growing. For more information, visit the company's website at www.kontrolenergy.com
Lincoln Educational Services Corp. (NASDAQ: LINC)
Lincoln Educational Services (NASDAQ: LINC) is a leading provider of hands-on, post-secondary career education solving America's skills gap by serving three key sectors: transportation, skilled trades and healthcare. After restructuring its operations, Lincoln has achieved nine consecutive quarters of growth and is now a profitable business with strong growth opportunities that will accelerate its profitability. The company currently trades at a discount to its peers and believes it is undervalued. For more information, visit the company's website at www.lincolntech.edu
Medexus Pharmaceuticals Inc. (TSXV: MDP) (OTCQB: PDDPF)
Medexus Pharmaceuticals (TSXV: MDP) (OTCQB: PDDPF) is a rapidly growing commercial-stage specialty pharmaceutical company with an established presence across North America. The company is focused on an array of therapeutic areas, including rheumatology, autoimmune disease, specialty oncology and pediatrics. For more information, visit the company's website at www.medexus.com
Milestone Scientific Inc. (NYSE: MLSS)
Milestone Scientific (NYSE: MLSS) is a biomedical technology research and development company that patents, designs, develops and commercializes innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary applications. Milestone's computer-controlled systems are designed to make injections precise, efficient and virtually painless. Milestone's proprietary DPS Dynamic Pressure Sensing technology® is a technology platform that advances the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle through platform extensions for local anesthesia for subcutaneous drug delivery, with specific applications for cosmetic botulinum toxin injections, epidural space identification in regional anesthesia procedures and intra-articular joint injections. For more information, visit the company's website at www.milestonescientific.com
Myomo Inc. (NYSE: MYO)
Myomo (NYSE: MYO) is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper limb paralysis. Myomo develops and markets the MyoPro product line. MyoPro is a powered upper limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. It is currently the only marketed device that, sensing a patient's own EMG signals through noninvasive sensors on the arm, can restore an individual's ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. For more information, visit the company's website at www.myomo.com
Nephros Inc. (NASDAQ: NEPH)
Nephros (NASDAQ: NEPH) is a commercial-stage company that develops and sells high-performance water purification products to the medical device and commercial markets. Nephros ultrafilters are used in hospitals and medical clinics for added protection in retaining bacteria (e.g., Legionella, Pseudomonas) and viruses from water, providing barriers that assist in improving infection control in showers, sinks and ice machines. Additionally, Nephros ultrafilters are used by dialysis centers for assisting in the added removal of endotoxins and other biological contaminants from the water and bicarbonate concentrate supplied to hemodialysis machines and patients. Nephros filters, including AETHER™ brand filters, improve the taste and odor of water and reduce biofilm, bacteria and scale build-up in downstream equipment. Nephros and AETHER™ products are used in the healthcare, food service, hospitality and convenience store markets. For more information, visit the company's website at www.nephros.com
Nova Leap Health Corp. (TSXV: NLH)
Nova Leap Health (TSXV: NLH) is an acquisitive home health care services company operating in one of the fastest growing industries in the U.S. and Canada. The company performs a vital role within the continuum of care with an individual and family-centered focus, particularly those requiring dementia care. Nova Leap achieved the No. 10 ranking in the 2019 TSX Venture 50™ in the Clean Technology & Life Sciences sector. The company is geographically diversified with operations in five different U.S. states – Vermont, New Hampshire, Massachusetts, Rhode Island and Oklahoma – as well as Nova Scotia, Canada. For more information, visit the company's website at www.NovaLeapHealth.com
OncoSec Medical Inc. (NASDAQ: ONCS)
OncoSec Medical (NASDAQ: ONCS) is a late-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target and attack cancer. OncoSec's lead product candidate, TAVO™ (tavokinogene telseplasmid), enables the intratumoral delivery of DNA-based interleukin-12 (IL-12), a naturally occurring protein with immune-stimulating functions. The technology, which employs electroporation, is designed to produce a controlled, localized expression of IL-12 in the tumor microenvironment, enabling the immune system to target and attack tumors throughout the body. OncoSec has built a deep and diverse clinical pipeline utilizing TAVO™ as a potential treatment for multiple cancer indications either as a monotherapy or in combination with leading checkpoint inhibitors. In addition to TAVO™, OncoSec is identifying and developing new DNA-encoded therapeutic candidates and tumor indications for use with its novel Visceral Lesion Applicator (VLA) to target deep internal lesions. For more information, visit the company's website at www.oncosec.com
Oragenics Inc. (NYSE: OGEN)
Oragenics (NYSE: OGEN) is focused on becoming a leader in novel antibiotics against infectious disease and on developing effective treatments for oral mucositis. The company has established two exclusive worldwide channel collaborations with Intrexon Corporation and its subsidiaries. The collaborations allow Oragenics to accelerate the development of much-needed new antibiotics that can work against resistant strains of bacteria and the development of biotherapeutics for oral mucositis and other diseases and conditions of the oral cavity, throat and esophagus. For more information, visit the company's website at www.oragenics.com
Perma-Fix Environmental Services Inc. (NASDAQ: PESI)
Perma-Fix Environmental Services (NASDAQ: PESI) is a nuclear services company and leading provider of nuclear and mixed-waste management services. The company's nuclear waste services include management and treatment of radioactive and mixed waste for hospitals; research labs and institutions; federal agencies, including the DOE and the Department of Defense; and the commercial nuclear industry. The company's nuclear services group provides project management; waste management; environmental restoration, decontamination and decommissioning; new build construction; and radiological protection, safety and industrial hygiene capability to its clients. The company operates three nuclear waste treatment facilities and provides nuclear services at DOE, DOD and commercial facilities nationwide. For more information, visit the company's website at www.perma-fix.com
Postal Realty Trust Inc. (NYSE: PSTL)
Postal Realty Trust (NYSE: PSTL) is an internally managed real estate investment trust that owns properties leased to the United States Postal Service. The company believes it is one of the largest owners and managers of properties leased to the USPS. The company's portfolio is comprised of 487 postal properties located in 45 states with 1.5 million net leasable interior square feet. For more information, visit the company's website at www.postalrealtytrust.com
QMX Gold Corp. (TSXV: QMX) (OTC: QMXGF)
QMX Gold (TSXV: QMX) (OTC: QMXGF) is a Quebec-focused exploration company with an extensive and underexplored land package on the Abitibi Greenstone Belt with a strong balance sheet, enviable exploration pipeline and strong corporate sponsorship (Eldorado Gold, Osisko Gold Royalties and Probe Metals). For more information, visit the company's website at www.qmxgold.ca
R.R. Donnelley & Sons Company (NYSE: RRD)
R.R. Donnelley & Sons (NYSE: RRD) is a leading global provider of multichannel business communications services and marketing solutions. With more than 50,000 clients and 36,400 employees across 29 countries, RRD offers the industry's most comprehensive offering of solutions designed to help companies optimize customer engagement and streamline business operations across the complete customer journey. RRD offers a comprehensive portfolio of capabilities, experience and scale that enables organizations around the world to create, manage, deliver and optimize their marketing and business communications strategies. For more information, visit the company's website at www.rrd.com
Sono-Tek Corp. (OTCQX: SOTK)
Sono-Tek (OTCQX: SOTK) is a global leader in ultrasonic coating systems, including the design, build, installation and service of solutions for R&D through high-volume manufacturing operations worldwide. The company has replaced or improved thousands of inefficient traditional coating methods in industries such as printed circuit board fluxing, electronics photoresist deposition, medical device coatings, and nanocoatings onto glass and textiles. In recent years, Sono-Tek introduced its ultrasonic technology into many new markets by leveraging its unique technologies, vast application knowledge and strong engineering team. New areas in which the company is increasing its presence include advanced robotic platforms, fuel cells and alternative energy solutions. Sono-Tek's financial results have benefited from a strategic shift to provide higher-value complete machine solutions and larger subsystems to OEMs. For more information, visit the company's website at www.sono-tek.com
SPI Energy Co. Ltd. (NASDAQ: SPI)
SPI Energy (NASDAQ: SPI) is a global provider of photovoltaic (PV) solutions for business, residential, government and utility customers and investors. The company develops solar PV projects that are either sold to third-party operators or owned and operated by the company for selling of electricity to the grid in multiple countries in Asia, North America and Europe. The company's subsidiary in Australia primarily sells solar PV components to retail customers and solar project developers. The company has its headquarters in Hong Kong and U.S. operating office in Santa Clara, California, and maintains global operations in Asia, Europe, North America and Australia. For more information, visit the company's website at www.spigroups.com
StageZero Life Sciences Ltd. (TSX: SZLS) (OTC: GNWSF)
StageZero Life Sciences (TSX: SZLS) (OTC: GNWSF) is dedicated to the early detection of cancer and multiple disease states through whole blood. Aristotle®, the company's next-generation test, is a panel for simultaneously screening for 10 cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle is built on the company's proven and proprietary Sentinel Principle Technology Platform, which has been validated on 10,000 patients and used to develop the first liquid biopsy for colorectal cancer, with further validation currently underway. In addition to building a pipeline of products for early cancer detection, the company operates a CAP-accredited and CLIA-certified reference laboratory based in Richmond, Virginia, that offers the ColonSentry® test as well as licensed biomarker tests for lung, breast and prostate cancers. For more information, visit the company's website at www.stagezerolifesciences.com
Synchronoss Technologies Inc. (NASDAQ: SNCR)
Synchronoss Technologies (NASDAQ: SNCR) transforms the way companies create new revenue, reduce costs and delight their subscribers with cloud, messaging, digital and IoT products, supporting hundreds of millions of subscribers across the globe. Synchronoss' secure, scalable and groundbreaking new technologies, trusted partnerships and talented people change the way TMT customers grow their businesses. For more information, visit the company's website at www.synchronoss.com
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP)
Tonix Pharmaceuticals (NASDAQ: TNXP) is a clinical-stage biopharmaceutical company committed to discovering and developing innovative and proprietary new therapeutics. The company's focus is on developing small molecules and biologics to treat psychiatric, pain and addiction conditions. Tonix's mission is to improve the lives of patients by identifying, researching and developing promising therapies that have the potential to address needs not currently fulfilled by existing products. For more information, visit the company's website at www.tonixpharma.com
Ur-Energy Inc. (TSX: URE)) (NYSE: URG)
Ur-Energy (TSX: URE) (NYSE: URG) is a uranium mining company in the seventh year of production operations at its Lost Creek in-situ recovery uranium facility in south-central Wyoming. In that time, Ur Energy quickly became the lowest-cost producer among publicly traded uranium companies. Those operating cost structures, as well as its original term contracts, have allowed the company to cash flow and continue operations in challenging markets. At 2019 Q3, Ur-Energy had captured approximately 2.7 million pounds of uranium into the Lost Creek plant. Ur-Energy has applications advancing with various agencies to incorporate the LC East project area into existing Lost Creek permits and to construct and operate at the company's second project, Shirley Basin. For more information, visit the company's website at www.ur-energy.com
VolitionRx Ltd. (NYSE: VNRX)
VolitionRx (NYSE: VNRX) is a multinational life sciences company developing simple, easy-to-use, cost-effective blood tests to help diagnose a range of cancers and other diseases. Early diagnosis has the potential to not only prolong the life of patients but also to improve their quality of life. The tests are based on the science of NucleosomicsTM, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid – an indication that disease is present. Volition's research and development activities are currently centered in Belgium, with additional offices in London, Texas and Singapore, as the company focuses on bringing its diagnostic products to market. For more information, visit the company's website at www.volitionrx.com
Vuzix Corp. (NASDAQ: VUZI)
Vuzix (NASDAQ: VUZI) is a leading supplier of smart glasses and augmented reality (AR) technologies and products for the consumer and enterprise markets. The company's products include personal display and wearable computing devices that offer users a portable, high-quality viewing experience and provide solutions for mobility, wearable displays and augmented reality. Vuzix holds 150 patents and patents pending and numerous IP licenses in the video eyewear field. The company has won Consumer Electronics Show (CES) awards for innovation for the years 2005 to 2020 and several wireless technology innovation awards, among others. For more information, visit the company's website at vuzix.com